Should terminally ill patients have the right to take drugs that pass phase I testing? No

AUTOR(ES)
FONTE

BMJ Publishing Group Ltd.

RESUMO

The United States is considering allowing experimental drugs to be given to people at the end of life. Emil J Freireich believes patients should be able to judge the risks for themselves, and Dean Gesme counters that use o such drugs outside trials will damage both individuals and science

Documentos Relacionados